Scott A. Kelly - 18 Oct 2021 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Chairman & CMO, Director
Signature
Michael D. Mulholland, Attorney-In-Fact
Issuer symbol
CYDY
Transactions as of
18 Oct 2021
Net transactions value
$0
Form type
4
Filing time
20 Oct 2021, 16:20:58 UTC
Previous filing
10 Aug 2021
Next filing
08 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified Stock Option Award $0 +1,750,000 $0.000000 1,750,000 18 Oct 2021 Common Stock 1,750,000 $1.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in 3 equal annual installments beginning on August 6, 2022, subject to Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.